S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CLRB Cellectar Biosciences Inc

0.282

-0.0346 (-10.93%)

Last Updated: 04:21:59

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Cellectar Biosciences Charts.

Cellectar Biosciences Inc News

Form 8-K - Current report
Thursday 13 March 2025 (6 hours ago) • Edgar (US Regulatory)

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
Thursday 13 March 2025 (7 hours ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 13 March 2025 (7 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 13 March 2025 (16 hours ago) • Edgar (US Regulatory)

Cellectar Biosciences to Present at the 37th Annual Roth Conference
Tuesday 11 March 2025 (2 days ago) • GlobeNewswire Inc.

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025
Thursday 6 March 2025 (1 week ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (4 weeks ago) • Edgar (US Regulatory)

More Cellectar Biosciences Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions